Jiangsu Gdk Biological Technology's high P/S ratio contrasts...
Jiangsu Gdk Biological Technology's high P/S ratio contrasts its declining revenue. Future disappointments for investors may follow if these align with the company's negative growth rates.
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more